Response to Berg et al. 'Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: A meta-analytic review' [2]

AIDS

Volumn 21, Issue 13, 2007, Pages 1830-1831

  Brown, Todd T ^a   Qaqish, Roula B ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

BODY MASS; BONE DENSITY; CLINICAL TRIAL; DATA ANALYSIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; META ANALYSIS; NUTRITIONAL DEFICIENCY; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; QUALITY CONTROL; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

ANTI-HIV AGENTS; BONE DENSITY; CONFOUNDING FACTORS (EPIDEMIOLOGY); HIV INFECTIONS; HUMANS; OSTEOPOROSIS;

EID: 34547766039     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3282703837     Document Type: Letter

References (7)

1. Berg KM, Klein RS, Schoenbaum EE, Arnsten JH. Interpreting the association between HIV and bone mineral density. AIDS 2007; 21:785-786.
2. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006; 20:2165-2174.
3. Gordis L. From association to causation: deriving inferences for epidemiologic studies. In: Epidemiology, 2nd edn.. Edited by Gordis L. Philadelphia, Pennsylvania: WB Saunders; 2000.
4. Lau J, Iaonnadias JPA, Schmid CH. Quantitative Synthesis in Systematic Reviews. In: Systematic reviews: synthesis of best evidence for healthcare decisions. Edited by Mulrow C, Cook D. Philadelphia: Am College of Physicians; 1998.
5. Blair A, Burg J, Foran J, Gibb H, Greenland S, Morris R, et al. Guidelines for application of meta-analysis in environmental epidemiology. ISLI Risk Science Institute. Regul Toxicol Pharmacol 1995; 22:189-197.
6. Greenland S. Invited commentary: a critical look at some popular meta-analytic methods. Am J Epidemiol 1994; 140:290-296.
7. Juni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282:1054-1060.